Charles River Laboratorie...

155.60
-2.46 (-1.56%)
At close: Mar 28, 2025, 3:59 PM
154.57
-0.66%
After-hours: Mar 28, 2025, 06:13 PM EDT

Company Description

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally.

It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing).

The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers.

This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services.

The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services.

The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products.

This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines.

The company also provides contract vivarium operation services to biopharmaceutical clients.

Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Charles River Laboratories International Inc.
Charles River Laboratories International Inc. logo
Country United States
IPO Date Jun 23, 2000
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 18,700
CEO James C. Foster J.D.

Contact Details

Address:
251 Ballardvale Street
Wilmington, Massachusetts
United States
Website https://www.criver.com

Stock Details

Ticker Symbol CRL
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001100682
CUSIP Number 159864107
ISIN Number US1598641074
Employer ID 06-1397316
SIC Code 8731

Key Executives

Name Position
James C. Foster J.D. Chairman, President & Chief Executive Officer
Birgit Girshick Corporate Executive Vice President & Chief Operating Officer
Flavia H. Pease Corporate Executive Vice President & Chief Financial Officer
Mark Mintz Corporate Senior Vice President & Chief Information Officer
Amy Cianciaruso Corporate Vice President & Chief Communications Officer
Joseph W. LaPlume J.D. Corporate Executive Vice President of Corporate Development & Strategy
Matthew L. Daniel J.D. Corporate Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer
Michael Gunnar Knell Corporate Senior Vice President & Chief Accounting Officer
Prof. Julie Frearson Ph.D. Corporate Senior Vice President & Chief Scientific Officer
Todd Spencer Corporate Vice President of Investor Relations

Latest SEC Filings

Date Type Title
Feb 26, 2025 4 Filing
Feb 21, 2025 4 Filing
Feb 21, 2025 4 Filing
Feb 21, 2025 4 Filing
Feb 21, 2025 8-K Current Report
Feb 19, 2025 10-K Annual Report
Feb 19, 2025 8-K Current Report
Feb 03, 2025 4 Filing
Feb 03, 2025 4 Filing
Feb 03, 2025 4 Filing